254 filings
Page 3 of 13
8-K
ha1di
7 Nov 22
Cara Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm
8-K
i41ain9m5hiv
3 Nov 22
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
7:12am
8-K
bxttnl1aozf 87f9
12 Sep 22
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
6:01am
8-K
aecuru wyfc6lnket
8 Aug 22
Cara Therapeutics CORPORATE PRESENTATION AUGUST 2022
4:11pm
8-K
1sgqxa
8 Aug 22
Cara Therapeutics Reports Second Quarter 2022 Financial Results
4:11pm
8-K
9v5j225mjl6xncb0c
30 Jun 22
Regulation FD Disclosure
7:01am
8-K
3lgydkyhvbts3akjcgi
7 Jun 22
Submission of Matters to a Vote of Security Holders
5:30pm
8-K
c0g8f7
3 Jun 22
Departure of Directors or Certain Officers
4:30pm
EFFECT
ieaytt04
12 May 22
Notice of effectiveness
12:15am
S-3/A
1yim6ew6op4ca43 gpm
9 May 22
Shelf registration (amended)
4:30pm
8-K
1yythym52z7ivyk
9 May 22
Cara Therapeutics Reports First Quarter 2022 Financial Results
4:10pm
CORRESP
8e4jd9lf6k2485
9 May 22
Correspondence with SEC
12:00am
CORRESP
o7lx 0q7wnckjd
26 Apr 22
Correspondence with SEC
12:00am
DEFA14A
469yiyr
22 Apr 22
Additional proxy soliciting materials
4:05pm
CORRESP
2kpvous1ssp8s
22 Apr 22
Correspondence with SEC
12:00am
8-K
t62b q6owlx0v8sx2ph
11 Mar 22
Cara Therapeutics CORPORATE PRESENTATION MARCH 2022
4:30pm
UPLOAD
ufgs 2i8vq
8 Mar 22
Letter from SEC
12:00am